Vascular effects of RWJ-676070, a selective combined V1a/V2 vasopressin receptor antagonist.


Autoria(s): Coltamai L.; Bucher M.; Maillard M.P.; Shukla U.; Bohidar N.; Haskell L.; Bertelsen K.; Fedgchin M.; Vogt B.; Burnier M.
Data(s)

2009

Identificador

http://serval.unil.ch/?id=serval:BIB_BC36EA0F8224

isbn:1532-6535

pmid:18987622

doi:10.1038/clpt.2008.217

isiid:000262816600015

Idioma(s)

en

Fonte

Clinical Pharmacology and Therapeutics, vol. 85, no. 2, pp. 145-148

Palavras-Chave #Adolescent; Adult; Benzazepines; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Male; Receptors, Vasopressin; Regional Blood Flow; Skin; Spiro Compounds; Young Adult
Tipo

info:eu-repo/semantics/article

article